Home > Financial Ratios > ALKEM LABORATORIES

ALKEM LABORATORIES
Core EBITDA Growth

    Back to All Ratios
ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for ALKEM LABORATORIES
Please provide your vote to see the results

ALKEM LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 40.03-17.601.8437.9031.20

What is the latest Core EBITDA Growth ratio of ALKEM LABORATORIES ?

The latest Core EBITDA Growth ratio of ALKEM LABORATORIES is 40.03 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202440.03
Mar2023-17.60
Mar20221.84
Mar202137.90
Mar202031.20

How is Core EBITDA Growth of ALKEM LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 40.03
Positive
Mar2023 -17.6
Negative
Mar2022 1.84
-95.15
Mar2021 37.9
21.47
Mar2020 31.2 -

Other Financial Ratios of ALKEM LABORATORIES


Compare Core EBITDA Growth ratio of peers of ALKEM LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALKEM LABORATORIES ₹60,543.3 Cr 2.2% -9.4% 2.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,228.0 Cr -2.4% -7.2% 27.2% Stock Analytics
DIVIS LABORATORIES ₹148,023.0 Cr 0% -9.2% 61.5% Stock Analytics
CIPLA ₹119,474.0 Cr 6% -3.8% 10.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,599.0 Cr 1.7% -11.4% 2.2% Stock Analytics
ZYDUS LIFESCIENCES ₹97,604.7 Cr 5.2% -2.1% 26.1% Stock Analytics


ALKEM LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALKEM LABORATORIES

2.2%

-9.4%

2.2%

SENSEX

1.7%

-1.3%

7.7%


You may also like the below Video Courses